Gheorghe Doros, PhD
Professor
Boston University School of Public Health
Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest
BS, University of Bucharest



Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Member
Boston University
BU-BMC Cancer Center




Screening for AL Amyloidosis in Smoldering Multiple Myeloma
03/01/2024 - 02/29/2028 (Subcontract PI)
Tufts Medical Center, Inc. NIH NCI
5R01CA279808-02

Salary Support for Gheorghe Doros, PhD
09/01/2025 - 08/31/2026 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2025 - 08/31/2026 (PI)
Baim Institute for Clinical Research


Biostatisics VA Support - Doros Group
08/26/2021 - 08/25/2026 (PI)
Department of Veterans Administration


General support for clinical studies at Baim Institute
09/01/2024 - 08/31/2025 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute 24'-25'
09/01/2024 - 08/09/2025 (PI)
Baim Institute for Clinical Research


Mechanistic underpinnings of increased adipose tissue in HFpEF
07/01/2019 - 06/30/2025 (Key Person)
PI: Flora Sam, MD
NIH/National Heart, Lung, and Blood Institute
5R01HL145985-04

BAIM Institute Student Suppport - Doros Group - for Luke Zheng
09/01/2023 - 09/01/2024 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


BAIM Institute Student Suppport - Doros Group - for Daniel Kojis
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


Showing 10 of 23 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Conte MS, Farber A, Liu IH, Chang RW, Doros G, Herman CR, Hiramoto JS, McGinigle KL, Siracuse JJ, Strong M, Menard MT. Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2026 Feb 16.View Related Profiles. PMID: 41708051
     
  2. Brooke BS, Doros G, Venermo M, Siracuse JJ, Abou-Zamzam AM, Dosluoglu HH, Motaganahalli RL, Menard MT, Farber A, Conte MS. Early Improvement in Wound, Ischaemia, and foot Infection (WIfI) Ischaemia Grade Lowers Risk of Major Amputation following Revascularisation for Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2026 Feb 02.View Related Profiles. PMID: 41638549
     
  3. Hicks CW, Farber A, Doros G, Kinlay S, Powell RJ, Strong MB, Rosenfield K, Aridi H, Motaganahalli R, Barleben A, Siracuse JJ, Azene E, Malas M, Conte MS, Zayed M, Menard MT. Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization. JACC Cardiovasc Interv. 2026 Jan 12; 19(1):96-107.View Related Profiles. PMID: 41534992; PMCID: PMC12810858; DOI: 10.1016/j.jcin.2025.10.065;
     
  4. Burke NJ, Mendelson LM, Joshi T, Libbey C, Burks EJ, Prokaeva T, Spencer B, Zheng L, Doros G, Sanchorawala V, Staron A. Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients. Amyloid. 2025 Dec 29; 1-9.View Related Profiles. PMID: 41460224; DOI: 10.1080/13506129.2025.2606847;
     
  5. Tan TW, Dansey KD, Farber A, Doros G, Menard MT, Rosenfield K, Conte MS, Venermo M, Kolh P, Strong MB, Singh N. High rates of nonindex limb amputation in the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial. J Vasc Surg. 2026 Mar; 83(3):905-913.View Related Profiles. PMID: 41242623; PMCID: PMC12735402; DOI: 10.1016/j.jvs.2025.11.009;
     
  6. Alabi O, Doros G, Hamouda M, Conte MS, Farber A, Kirksey L, Menard MT, Kernodle A, McGinigle K, Moreira C, Rosenfield K, Strong MB, Ulloa JG, Kaufman JA, Malas M, Rowe VL. Examination of Race and Ethnicity After Revascularization in the BEST-CLI Trial. Ann Surg. 2025 Nov 11.View Related Profiles. PMID: 41214473
     
  7. Powell RJ, Menard MT, Rosenfield K, Strong MB, Conte MS, Doros G, Ezra A, Garg N, Mena-Hurtado C, Lane JS, Shah SK, Venermo M, Zhou W, Farber A. Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI Trial. J Vasc Surg. 2026 Apr; 83(4):1160-1170.View Related Profiles. PMID: 41205838
     
  8. Song Y, Fava M, Kim C, Yeh RW, Doros G. Estimating Causal Treatment Effects in the Sequential Parallel Comparison Design (SPCD). Stat Med. 2025 Nov; 44(25-27):e70319. PMID: 41249861
     
  9. Avila Rodriguez AM, Hu X, Varga C, Comenzo R, Sarosiek S, Sloan JM, Sanchorawala V, Doros G, Quillen K. Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as outpatient versus inpatient. Br J Haematol. 2025 Oct; 207(4):1679-1683.View Related Profiles. PMID: 40898649; PMCID: PMC12512066; DOI: 10.1111/bjh.70104;
     
  10. Alameddine D, Hamouda M, Doros G, Conte MS, Rosenfield K, Strong MB, Menard MT, Farber A, Hamdan A, Malas M, Ochoa Chaar CI. Insulin therapy and outcomes of revascularization procedures for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2026 Jan; 83(1):246-255.e3.View Related Profiles. PMID: 40886741; DOI: 10.1016/j.jvs.2025.08.033;
     
Showing 10 of 380 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 380 publications over 24 distinct years, with a maximum of 41 publications in 2014

YearPublications
20031
20041
20051
20063
20077
20084
200914
201014
201115
20129
201321
201441
201539
201628
201739
201836
201923
202011
202114
202214
20239
202413
202520
20263

2008-2010 Boston University School of Public Health: Excellence in Teaching Award
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Doros's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department